Search Ontology:
ChEBI
aprepitant
- Term ID
- CHEBI:499361
- Synonyms
-
- 3-(((2R,3S)-3-(p-Fluorophenyl)-2-(((alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-Delta(2)-1,2,4-triazolin-5-one
- 5-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-one
- aprepitant
- aprepitantum
- Definition
- A morpholine-based antiemetic, which is or the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy. Aprepitant is a selective high-affinity antagonist of human substance P/neurokinin 1 (NK1) receptors.
- References
-
- CAS:170729-80-3
- DrugBank:DB00673
- Drug_Central:230
- HMDB:HMDB0014811
- KEGG:D02968
- LINCS:LSM-5637
- PMID:21415280
- PMID:22141732
- PMID:22187110
- PMID:22260216
- PMID:22995650
- PMID:23062719
- PMID:23191934
- PMID:23370141
- PMID:23560185
- Reaxys:8096869
- Wikipedia:Aprepitant
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
Phenotype
Phenotype resulting from aprepitant
Phenotype where environments contain aprepitant
Phenotype modified by environments containing aprepitant
Human Disease Model